Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Gan & Lee Pharmaceuticals.
  6. News
  7. Summary
    603087   CNE100003ZH1

GAN & LEE PHARMACEUTICALS.

(603087)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Gan & Lee Pharmaceuticals Co., Ltd.(SHSE:603087) added to Shanghai Stock Exchange 180 Value Index

12/21/2020 | 12:00am EST

Gan & Lee Pharmaceuticals Co., Ltd. has been added to Shanghai Stock Exchange 180 Value Index .


ę S&P Capital IQ 2020
All news about GAN & LEE PHARMACEUTICALS.
11/28China’s Drug Procurement Program Cuts Insulin Costs by Around 48%
MT
10/27Gan & Lee Pharmaceuticals. Reports Earnings Results for the Nine Months Ended September..
CI
10/14GAN & LEE PHARMACEUTICALS : Concludes Phase 3 Studies of Gan & Lee Insulin Glargine (GL-GL..
AQ
08/26Gan & Lee Pharmaceuticals. Reports Earnings Results for the Half Year Ended June 30, 20..
CI
07/02GAN & LEE PHARMACEUTICALS : New Data on Phase 1 Proposed Biosimilar Gan & Lee Insulins Asp..
AQ
07/02Gan & Lee Pharmaceuticals Co., Ltd. Announces Positive Phase 1 Clinical Trial Results a..
CI
04/29Gan & Lee Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ende..
CI
04/14Gan & Lee Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended De..
CI
04/06GAN & LEE PHARMACEUTICALS : & Lee Pharma's Tumor Drug Wins Orphan Drug Designation in Euro..
MT
03/21GAN & LEE PHARMACEUTICALS CO., LTD.( : 603087) added to FTSE All-World Index
CI
More news
Financials
Sales 2021 3 786 M 595 M 595 M
Net income 2021 1 436 M 226 M 226 M
Net Debt 2021 - - -
P/E ratio 2021 27,8x
Yield 2021 -
Capitalization 40 004 M 6 283 M 6 284 M
Capi. / Sales 2021 10,6x
Capi. / Sales 2022 9,58x
Nbr of Employees 2 934
Free-Float 17,2%
Chart GAN & LEE PHARMACEUTICALS.
Duration : Period :
Gan & Lee Pharmaceuticals. Technical Analysis Chart | 603087 | CNE100003ZH1 | MarketScreener
Technical analysis trends GAN & LEE PHARMACEUTICALS.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 71,24 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Zhong Ru Gan Chairman
Yan Sun Independent Director
Yan Qing He Independent Director
Guo Jun Zheng Independent Director
Kai Du Director & Director-International Department
Sector and Competitors
1st jan.Capi. (M$)
GAN & LEE PHARMACEUTICALS.-46.12%6 264
CSL LIMITED6.57%95 165
WUXI BIOLOGICS (CAYMAN) INC.-5.64%52 197
SAMSUNG BIOLOGICS CO.,LTD.6.17%50 476
ALEXION PHARMACEUTICALS, INC.0.00%40 336
BIOGEN INC.-8.47%32 920